Neoantigens Enable Personalized Cancer Immunotherapy – The Scientist
The Scientist |
Neoantigens Enable Personalized Cancer Immunotherapy
The Scientist One type of immunotherapy in which a tumor's neoantigens are suspected to play a role is immune checkpoint inhibitors, which block inhibitory signals that would otherwise repress the body's cancer-fighting T cells. In both preclinical models and human … |
